Key result
Noninvasive methods of measuring baroreflex sensitivity correlated with the phenylephrine technique but underestimated it and could not be used interchangeably.
Why the study?
Do noninvasive measures of baroreflex sensitivity correlate with the established phenylephrine bolus method in aging and hypertensive patients?
Cross-Sectional (n=149)
Do noninvasive measures of baroreflex sensitivity correlate with the established phenylephrine bolus method in aging and hypertensive patients?
Noninvasive methods of measuring baroreflex sensitivity correlate with the phenylephrine bolus technique but cannot be used interchangeably, though spectral domain analysis effectively detects hypertension-related baroreflex loss.
Answers are grounded in this paper and cite their sources.
Noninvasive baroreflex measures should not replace phenylephrine testing in practice; leaves open their research utility for detecting hypertension-related impairment.
BACKGROUND: Phenylephrine bolus injection is an established technique to measure baroreflex sensitivity (BRS). This study quantified the relationship between the phenylephrine method and noninvasive measures of BRS and examined the effects of aging and hypertension on BRS. We also examined whether heart rate variability (HRV) provides as much information as does BRS. METHODS: BRS was determined by phenylephrine bolus (BRSphe), amyl nitrite inhalation (BRSamyl), Valsalva maneuver (BRSVals) and by time (BRS(+)) and spectral domain analysis (BRS(LFalpha), 004-015 Hz) of spontaneous blood pressure and R-R interval changes over the 5-min time period. RESULTS: The phenylephrine method significantly correlated with other methods (BRS(LFalpha) R = 0.54, BRS(+) R = 0.55, BRSVals R = 0.43 and BRSamyl R = 0.39; P < or = 0.001). Each method underestimated the BRSphe by the factors 0.62, 0.64, 0.59 and 0.33, respectively; P value less than 0.001. Only BRS(LFalpha) was significantly different between normotensive and hypertensive patients in young [24.3 +/- 1.4 (n = 40) vs. 12.2 +/- 2.3 (n = 7)] and middle-aged [16.5 +/- 1.1 (n = 71) vs. 10.8 +/- 1.1 (n = 31) groups, respectively]. HRV in the high frequency band (0.15-0.40 Hz) was significantly lower in young hypertensive patients than in normal controls (26 +/- 6.0 vs. 50 +/- 2.4, P < 0.05). CONCLUSION: Although all methods correlated with the phenylephrine technique, none of them could be used interchangeably with that technique. BRS(LFalpha) detected the baroreflex loss of hypertension most clearly, and BRSamyl did not differ among groups.
No takes yet. Share an insight, caveat, or question.
Milic et al. (2009) conducted a cross-sectional in Hypertension (n=149). Noninvasive measures of baroreflex sensitivity vs. Phenylephrine bolus injection was evaluated on Correlation between phenylephrine method and noninvasive measures of BRS (R = 0.39 to 0.55, p=≤0.001). Noninvasive methods of measuring baroreflex sensitivity correlated with the phenylephrine technique but underestimated it and could not be used interchangeably.
Synapse has enriched 10 related papers. Consider them for comparative context: